CHIPS Act: What 192 SEC Filings Reveal About Subsidy Risk

The CHIPS Act appears in 192 operational SEC filings from over 30 companies spanning 30 industries — but the most important finding isn't how many companies mention it. It's that the same federal subsidy is creating three incompatible financial structures across its largest recipients. Intel's grants were converted into dilutive government equity. Micron's $6.4 billion in awards explicitly restrict share buybacks. Texas Instruments adds $335 million in CHIPS proceeds directly to its non-GAAP free cash flow definition, inflating the most-watched metric in semiconductor investing by 14%. Investors screening chip stocks on free cash flow margin, buyback yield, or dilution risk are now comparing numbers shaped by structurally different subsidy arrangements — and the distortion is set to intensify as the investment tax credit rises from 25% to 35% for post-2025 assets.

Intel: When Grants Become Government Equity

Intel's CHIPS Act relationship fundamentally changed in Q3 2025. The U.S. government converted Intel's remaining grant funding into equity investments, making the government one of Intel's largest stockholders. Intel lost its contractual right to receive future grants and disclosed the equity issuance as dilutive to existing stockholders.

The transactions eliminate our contractual rights to receive future funds under the commercial CHIPS Act agreement and Secure Enclave agreement in the form of grants and may limit our ability to secure grants from government entities in the future. In converting future grant funding into investments in common stock by the U.S. government, the transactions make it such that we will no longer benefit from the reduced future operating costs made possible by such grant funding.

This is the only known case of CHIPS Act grants being restructured into government equity. Intel went from receiving cost-reducing subsidies to having a government shareholder whose "interests in us may not be the same as those of other stockholders" — a fundamentally different governance structure than any other CHIPS Act recipient faces. In practice, a government shareholder with divergent interests could exercise influence through export licensing constraints, national security-driven fab location mandates, or executive compensation limits tied to the CHIPS Act appropriation terms — governance exposures that appear in no other semiconductor company's risk factor disclosures.

Micron: $6.4 Billion in Grants, Buybacks on Hold

Micron has secured up to $6.4 billion in total CHIPS Act grants — $6.1 billion for fabs in Idaho and New York, plus $275 million for Virginia modernization. The first Idaho fab targets mid-2027 DRAM output; a second Idaho fab should be operational by end of 2028. New York broke ground in January 2026 with supply expected in 2030 and beyond.

The strings attached are explicit. The grants carry clawback provisions, audit rights, and direct restrictions on capital returns:

The repurchase authorization has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions, restrictions applicable under our CHIPS Act direct funding agreements, and our ongoing determination of the best use of available cash.

Micron's $6.4 billion in CHIPS Act grants directly constrains the company's share repurchase authorization, creating a structural trade-off between government-subsidized capacity expansion and shareholder capital returns that will persist through the end of the decade.

Texas Instruments: The 14% Free Cash Flow Illusion

TXN received $335 million in CHIPS Act incentives in the first nine months of 2025 — and then did something no other recipient has done publicly: added that amount directly to its non-GAAP free cash flow definition.

Free cash flow is calculated as cash flows from operating activities (also referred to as cash flow from operations) less capital expenditures, plus proceeds from CHIPS Act incentives.

The impact is material. TXN's non-GAAP free cash flow for the twelve months ended September 2025 was $2,415 million (14.0% of revenue), versus $1,468 million (9.3%) in the prior year — a 65% increase. The $335 million in CHIPS proceeds that did not exist in the prior period represents 14% of that headline figure. With TXN expecting up to $1.6 billion in direct funding for three 300mm fabs and the ITC increasing from 25% to 35% after December 2025, this non-GAAP distortion will grow in future periods.

Texas Instruments' CHIPS Act proceeds account for 14% of its reported non-GAAP free cash flow — a metric inflator invisible to screeners that pull the headline number without reading the reconciliation footnote.

Beyond the Fab Floor: Packaging, Materials, and the Award-Cash Gap

The CHIPS Act's influence extends past chip fabrication. Amkor Technology received a $407 million award for the first advanced semiconductor packaging facility built in the U.S. under the CHIPS Act. But as of its 10-K filing date, zero funds had been received:

In December 2024, we signed a Direct Funding Agreement with the Commerce Department for the award of up to $407 million in government incentives pursuant to the CHIPS Act, and no funds have been received to date.

Entegris, meanwhile, received a $77 million grant — 83 times smaller than Micron's — for its Colorado Springs materials facility. Entegris frames the CHIPS Act not as a direct subsidy but as a demand catalyst, positioning itself as a "reliable local supply chain partner" for the wave of new U.S. fabs. The company's risk disclosure captures the structural exposure facing every supply-chain grant recipient:

The timing of any reimbursements or funding may not align with our capital spending or operating needs, and we may be required to fund substantial costs in advance of receiving any benefits (if received at all).

Amkor's $407 million CHIPS Act award with zero dollars received illustrates the gap between headline awards and actual cash flow — a pattern investors cannot see from press releases alone.

The Pattern: One Law, Three Financial Fingerprints

The CHIPS Act is not a uniform subsidy. It has fragmented into at least three distinct financial structures that make traditional peer comparisons unreliable.

Government equity at Intel — grants converted to dilutive common stock, creating a government shareholder with potentially different interests than other stockholders. No other recipient faces this governance overhang.

Conditional grants with capital restrictions at Micron, Amkor, and Entegris — direct funding tied to milestones, subject to clawback and audit, with explicit limits on share repurchases and other activities. The gap between award and disbursement means headline figures overstate near-term cash benefit.

Non-GAAP metric adjustment at Texas Instruments — CHIPS proceeds added as a line item to free cash flow, directly inflating the metric most commonly used to evaluate semiconductor cash generation. No peer has adopted this definition.

This divergence matters now because the One Big Beautiful Bill Act (enacted July 2025) raised the CHIPS Act ITC from 25% to 35% for assets placed in service after 2025. As the tax credit grows, so does the gap between companies that add it to non-GAAP metrics and those that don't — making the comparability problem worse, not better, in future quarters.

Three things to watch:

1. Whether other semiconductor companies adopt TXN's approach of adding CHIPS proceeds to non-GAAP free cash flow definitions — or whether regulators push back
2. The gap between CHIPS Act awards announced and cash actually received — Amkor's $0-on-$407M pattern may be common across smaller recipients
3. Intel's governance disclosures as the U.S. government exercises stockholder rights — proxy statements will be the leading indicator

Frequently Asked Questions

What is the CHIPS Act and why does it matter for investors?

The CHIPS and Science Act of 2022 provides federal subsidies for U.S. semiconductor manufacturing. It matters for investors because the same law creates structurally different financial impacts across recipient companies — government equity at Intel, conditional grants with buyback restrictions at Micron, and non-GAAP metric adjustments at Texas Instruments — making standard peer comparisons unreliable.

How much CHIPS Act funding has been awarded to semiconductor companies?

Based on SEC filings reviewed, Micron has secured up to $6.4 billion across Idaho, New York, and Virginia facilities. Texas Instruments expects up to $1.6 billion for three 300mm fabs. Amkor received a $407 million award for its Arizona packaging facility. Entegris received $77 million for Colorado Springs. Intel's grants were converted to government equity in Q3 2025.

Does the CHIPS Act affect semiconductor company share buybacks?

Yes. Micron's 10-Q explicitly states that its share repurchase authorization is "subject to restrictions applicable under our CHIPS Act direct funding agreements." This creates a direct link between federal industrial policy and shareholder capital allocation that investors must factor into buyback capacity estimates.

How does Texas Instruments account for CHIPS Act proceeds in its financials?

Texas Instruments adds CHIPS Act proceeds as a separate line item in its non-GAAP free cash flow definition: "cash flows from operating activities less capital expenditures, plus proceeds from CHIPS Act incentives." In the twelve months ended September 2025, $335 million in CHIPS proceeds represented 14% of TXN's reported non-GAAP free cash flow of $2,415 million.

Which industries beyond semiconductors mention the CHIPS Act in SEC filings?

While 51% of operational filings come from semiconductor companies (SIC 3674), CHIPS Act mentions span 30 SIC industries including metal mining, construction, electric services, plastics, optical instruments, and state commercial banking — reflecting the law's broad supply-chain impact beyond chip fabrication.

Methodology

This analysis used MetricDuck's SEC filing intelligence tools to search 192 operational filings across 5 form types (10-K, 10-Q, 8-K, S-1, DEF 14A) for "CHIPS Act" and "CHIPS and Science Act." We identified 5 companies with substantive disclosures representing distinct financial structures and analyzed their filing sections for cross-company patterns.

Tools used: SEC EDGAR Full-Text Search (EFTS) for landscape discovery across all 352 filings, MetricDuck filing intelligence for company-level triage and signal extraction, and the filing section reader for verbatim evidence extraction from risk factors, MD&A liquidity, MD&A results of operations, and business description sections.

Limitations:

• Keyword-based search captures only filings that explicitly mention "CHIPS Act" — companies receiving CHIPS-adjacent benefits (state-level incentives, supply chain contracts) without naming the law are not captured
• Analysis covers the 12-month window from March 2025 to March 2026; earlier filings from the initial award period (2022–2024) are outside scope
• Non-GAAP metric definitions were compared across five companies; a comprehensive survey of all 30+ filers' treatment would require additional analysis

Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. All data is derived from public SEC filings and may contain errors from the automated extraction process. Past disclosures do not predict future subsidy structures or financial outcomes.